This invention regards the percutaneous absorption formulation which the dosage sushi can in stability the anti- acknowledgment symptom medicine over the long period of time of 1 weeks. In detail, as for this invention, the anti- acknowledgment symptom remedy medicine, the high polymer which possesses the amino group, the polyatomic alcohol fatty acid ester, including the polyatomic alcohol, polyvalent carboxylic acid ester, and the styrene type high polymer, including the medicine content formation which becomes, it becomes, it regards the percutaneous absorption formulation of the anti- acknowledgment symptom medicine.本発明は、抗認知症薬物を1週間程度の長期間にわたり安定に投与すしうる経皮吸収製剤に関する。より詳細には、本発明は、抗認知症治療薬物、アミノ基を有する高分子化合物、多価アルコール脂肪酸エステル、多価アルコール、多価カルボン酸エステル、およびスチレン系高分子化合物を含んでなる薬物含有層を含んでなる、抗認知症薬物の経皮吸収製剤に関する。
